Recent medical research funding cuts have raised alarm among healthcare professionals and researchers alike, as they threaten the very fabric of patient safety in clinical studies.The implications of these funding reductions extend far beyond administrative numbers; they jeopardize the systemic oversight necessary for effective and ethical research practices, particularly those enforced by Institutional Review Boards (IRBs).